What Drives Drug Pricing?

High drug prices have seized headlines, angered patient advocates, and prompted congressional hearings. Many causes have been suggested — among them, a fragmented pharmaceutical market that limits competition, the quest for profits (whether to fund expensive R&D or otherwise), and government regulations that bar Medicare from negotiating prices. Harder to find are solutions for patients who cannot afford their therapies. Venture capitalists may be a unique leverage point on the system because their investments can encourage risk-taking and the development of novel, high-impact medicines, shifting the locus of industry’s search for rewards. How do we encourage a drug-development system that innovates, while keeping lifesaving therapies affordable?

Festival: Aspen Ideas 2017

More on this Session

Watch and Listen: Policy

Medical errors in hospitals rank as the third leading cause of death in the United States, exceeded only by cancer and... See more
US Senator Mitch McConnell has just announced that he will bring health reform legislation to the Senate floor for a... See more
Dip into a groundbreaking medical memoir by Kurt Newman, president and CEO of Children’s National Medical Center and... See more
Individual genetic makeup and the genetic signature of diseases vary tremendously, but the goal of matching them with... See more
As climate change increasingly becomes a fact of daily life, the health hazards of rising sea levels, catastrophic... See more
The world of health care, and how to deliver it, is a constant topic for headlines. Beyond congressional wrangling over... See more

Pages